Zeillinger R - Search Results

1

An interleukin-6 gene promoter polymorphism and unexplained late intrauterine fetal death: a multicenter study.

Huber A, Grimm C, Jirecek S, Zeillinger R, Heim K, Husslein P, Hefler L. Huber A, et al. Among authors: zeillinger r. J Soc Gynecol Investig. 2005 Jan;12(1):33-6. doi: 10.1016/j.jsgi.2004.08.001. J Soc Gynecol Investig. 2005. PMID: 15629668

2

Fetal fibronectin as a selection criterion for induction of term labor.

Ahner R, Egarter C, Kiss H, Heinzl K, Zeillinger R, Schatten C, Dormeier A, Husslein P. Ahner R, et al. Among authors: zeillinger r. Am J Obstet Gynecol. 1995 Nov;173(5):1513-7. doi: 10.1016/0002-9378(95)90641-x. Am J Obstet Gynecol. 1995. PMID: 7503193

3

Fetal fibronectin as a marker to predict the onset of term labor and delivery.

Ahner R, Kiss H, Egarter C, Zeillinger R, Eppel W, Karas H, Husslein P. Ahner R, et al. Among authors: zeillinger r. Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):134-7. doi: 10.1016/0002-9378(95)90101-9. Am J Obstet Gynecol. 1995. PMID: 7847522

4

Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer.

Obermair A, Tempfer C, Hefler L, Preyer O, Kaider A, Zeillinger R, Leodolter S, Kainz C. Obermair A, et al. Among authors: zeillinger r. Br J Cancer. 1998 Jun;77(11):1870-4. doi: 10.1038/bjc.1998.311. Br J Cancer. 1998. PMID: 9667661 Free PMC article.

5

Cytosol concentrations of CD44 isoforms in breast cancer tissue.

Hefler L, Tempfer C, Haeusler G, Kucera E, Mayerhofer K, Zeillinger R, Reinthaller A, Kainz C. Hefler L, et al. Among authors: zeillinger r. Int J Cancer. 1998 Oct 23;79(5):541-5. doi: 10.1002/(sici)1097-0215(19981023)79:5<541::aid-ijc17>3.0.co;2-4. Int J Cancer. 1998. PMID: 9761127 Free article.

6

Humoral p53 antibody response is a prognostic parameter in ovarian cancer.

Mayerhofer K, Tempfer C, Kucera E, Hefler L, Zeisler H, Kainz C, Zeillinger R, Sliutz G. Mayerhofer K, et al. Among authors: zeillinger r. Anticancer Res. 1999 Jan-Feb;19(1B):875-8. Anticancer Res. 1999. PMID: 10216509

7

P53 antibody response in patients with vulvar cancer.

Mayerhofer K, Hefler L, Schindl M, Concin N, Frischmuth K, Leodolter S, Zeillinger R, Reinthaller A, Kainz C. Mayerhofer K, et al. Among authors: zeillinger r. Anticancer Res. 1999 May-Jun;19(3B):2323-6. Anticancer Res. 1999. PMID: 10472352

8

Interleukin-8 serum level shift in patients with ovarian carcinoma undergoing paclitaxel-containing chemotherapy.

Mayerhofer K, Bodner K, Bodner-Adler B, Schindl M, Kaider A, Hefler L, Zeillinger R, Leodolter S, Joura EA, Kainz C. Mayerhofer K, et al. Among authors: zeillinger r. Cancer. 2001 Jan 15;91(2):388-93. Cancer. 2001. PMID: 11180086

9

Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage.

Tempfer C, Unfried G, Zeillinger R, Hefler L, Nagele F, Huber JC. Tempfer C, et al. Among authors: zeillinger r. Hum Reprod. 2001 Aug;16(8):1644-7. doi: 10.1093/humrep/16.8.1644. Hum Reprod. 2001. PMID: 11473956

10

Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients.

Tong D, Fabjani G, Heinze G, Obermair A, Leodolter S, Zeillinger R. Tong D, et al. Among authors: zeillinger r. Int J Cancer. 2001 Nov 20;95(6):394-7. doi: 10.1002/1097-0215(20011120)95:6<394::aid-ijc1070>3.0.co;2-x. Int J Cancer. 2001. PMID: 11668524 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page